Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease.

Kulkarni, Smita, Ying Qi, Colm O’hUigin, Florencia Pereyra, Veron Ramsuran, Paul McLaren, Jacques Fellay, et al. 2013. “Genetic Interplay Between HLA-C and MIR148A in HIV Control and Crohn Disease.”. Proceedings of the National Academy of Sciences of the United States of America 110 (51): 20705-10.

Abstract

Variation in the 3' untranslated region (3'UTR) of the HLA-C locus determines binding of the microRNA Hsa-miR-148a, resulting in lower cell surface expression of alleles that bind miR-148a relative to those alleles that escape its binding. The HLA-C 3'UTR variant was shown to associate with HIV control, but like the vast majority of disease associations in a region dense with causal candidates, a direct effect of HLA-C expression level on HIV control was not proven. We demonstrate that a MIR148A insertion/deletion polymorphism associates with its own expression levels, affecting the extent to which HLA-C is down-regulated, the level of HIV control, and the risk of Crohn disease only among those carrying an intact miR-148a binding site in the HLA-C 3'UTR. These data illustrate a direct effect of HLA-C expression level on HIV control that cannot be attributed to other HLA loci in linkage disequilibrium with HLA-C and highlight the rich complexity of genetic interactions in human disease.

Last updated on 03/27/2023
PubMed